Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
Welsbach Technology Metals Acquisition Corp. (WTMAU) Prices 7.5M Unit IPO at $10/unit
-
Welsbach Technology Metals Acquisition Corp. Announces Pricing of $75 Million Initial Public Offering
-
Welsbach Technology Metals Acquisition Corp. Announces Pricing of $75 Million Initial Public Offering
-
Gardiner Healthcare Acquisitions Corp. Announces Closing of $75 Million Initial Public Offering
-
UPDATE: Chardan Capital Markets Starts Pear Therapeutics (PEAR) at Buy
-
Gardiner Healthcare Acquisitions Corp (GDNRU) Prices 7.5M Unit IPO at $10/unit
-
Gardiner Healthcare Acquisitions Corp. Announces Pricing of $75 Million Initial Public Offering
-
GLOBALINK INVESTMENT INC. ANNOUNCES THE SEPARATE TRADING OF ITS COMMON STOCK, RIGHTS AND WARRANTS, COMMENCING DECEMBER 22, 2021
-
GLOBALINK INVESTMENT INC. ANNOUNCES THE SEPARATE TRADING OF ITS COMMON STOCK, RIGHTS AND WARRANTS, COMMENCING DECEMBER 22, 2021
-
Ventoux CCM Acquisition Corp. and Presto Announce Confidential Submission of Registration Statement in Connection with the Proposed Business Combination
-
Sonnet BioTherapeutics (SONN) PT Lowered to $2.50 at Chardan Capital Markets
-
Forafric to go Public Via Merger with Globis Acquisition Corp (GLAQ)
-
Nauticus Robotics to Become Publicly Traded Company Via Merger with CleanTech Acquisition Corp. (CLAQ)
-
Nauticus Robotics, a Developer of Cloud-Based AI Software to Power its Ocean Robots and Services, to Become a Publicly Traded Company Via Merger with CleanTech Acquisition Corp.
-
Nauticus Robotics, a Developer of Cloud-Based AI Software to Power its Ocean Robots and Services, to Become a Publicly Traded Company Via Merger with CleanTech Acquisition Corp.
-
Medallion Resources Provides Corporate Update
-
Cabaletta Bio Inc. (CABA) PT Lowered to $17 at Chardan Capital Markets, Keeps 'Buy'
-
Chardan Capital Markets Reiterates Buy Rating on Immatics (IMTX) on BMY Deal
-
GLOBALINK INVESTMENT INC. ANNOUNCES EXERCISE AND CLOSING OF OVER-ALLOTMENT OPTION IN PUBLIC OFFERING
-
GLOBALINK INVESTMENT INC. ANNOUNCES EXERCISE AND CLOSING OF OVER-ALLOTMENT OPTION IN PUBLIC OFFERING
-
UPDATE: Chardan Capital Markets Downgrades Exicure (XCUR) to Neutral
-
GLOBALINK INVESTMENT INC. ANNOUNCES CLOSING OF $100 MILLION INITIAL PUBLIC OFFERING
-
GLOBALINK INVESTMENT INC. ANNOUNCES CLOSING OF $100 MILLION INITIAL PUBLIC OFFERING
-
Insignia Systems (ISIG) Stock is Up Over 100% Today, 330% This Week. Here's Why
-
IPO for SPAC Globalink Investment Inc. (GLLI) Opens at $10.12
-
Globalink Investment Inc. (GLLIU) Prices 10M Unit IPO at $10/unit
-
Globalink Investment Inc. Announces Pricing of $100 Million Initial Public Offering on NASDAQ
-
Globalink Investment Inc. Announces Pricing of $100 Million Initial Public Offering on NASDAQ
-
Insignia Systems (ISIG) Announces Review of Strategic Alternatives
-
Insignia Systems, Inc. Announces Review of Strategic Alternatives
-
Penny Stocks To Watch Today: ABUS, Moderna, A Big Win For Small Caps
-
Krystal Biotech (KRYS) Prices 2.67M Share Offering at $75/sh
-
Krystal Biotech Announces Pricing of $200 Million Public Offering of Common Stock
-
Arisz Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing December 9, 2021
-
Arisz Acquisition Corp. Announces the Separate Trading of its Common Stock, Rights and Warrants, Commencing December 9, 2021
-
Krystal Biotech (KRYS) PT Raised to $140 at Chardan Capital Markets, Following Clinical Business Update
-
Arisz Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Arisz Acquisition Corp. Announces Exercise and Closing of Over-Allotment Option in Public Offering
-
Better Therapeutics (BTTX) Gains 20%+ Following New Buy Rating
-
UPDATE: Chardan Capital Markets Starts Better Therapeutics (BTTX) at Buy
-
Arisz Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
-
Arisz Acquisition Corp. Announces Closing of $60 Million Initial Public Offering
-
Mountain Crest Acquisition Corp. V Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
IPO for SPAC Arisz Acquisition Corp. (ARIZ) Opens at $10.11
-
Arisz Acquisition Corp. (ARIZ) Prices 6M Unit IPO at $10/unit
-
Arisz Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering on NASDAQ
-
Arisz Acquisition Corp. Announces Pricing of $60 Million Initial Public Offering on NASDAQ
-
Monterey Bio Acquisition Corporation Announces the Separate Trading of its Common Stock and Warrants, Commencing November 22, 2021
-
Mountain Crest Acquisition Corp. V Announces Closing of $60 Million Initial Public Offering
-
Form 10-Q Chardan NexTech Acquisit For: Sep 30

